Author Archives: donttradeourlivesaway

Withdrawal Of GSP By the US is India’s Opportunity to End Loot By Big Pharma

Source : Newsclick 14 march,2019,New Delhi Now, there is all the more reason for the government to place peoples’ health above the trade interests and impose price control on all the medical devices notified as drugs under the Drugs and … Continue reading

Posted in Access to Medecines | Leave a comment

Using compulsory licence for affordable medicines

Source: Astro Awani 14 March,2019,New Delhi RECENTLY, Malaysia made headlines again for its “government use” compulsory license (CL) to gain access to a generic version of a Hepatitis C medicine called Sofosbuvir.Malaysia has been facing pressure from pharmaceutical companies and … Continue reading

Posted in Access to Medecines | Leave a comment

Will US Drug Pricing Politics Change Intimidation Practices Globally?

Source: Intellecutual Property Watch 14 March 2019, New Delhi By Fifa Rahman* The global health world, particularly as concerns skyrocketing drug prices and patent abuse, is in a unique space in time. Recently, the Office of the United States Trade … Continue reading

Posted in Access to Medecines | Leave a comment

INDONESIAN ACTIVISTS STORM 25TH RCEP NEGOTIATIONS IN BALI

25th Feb 2019, New Delhi Source: People Over Profit Members of SERUNI women’s organization, Front Perjuangan Rakyat (FPR), Papuan Student Alliance, and People Over Profit-Indonesia stormed the 25th meeting of the Trade Negotiating Committee of the Regional Comprehensive Partnership Agreement … Continue reading

Posted in Regional Comprehensive Economic Partnership | Leave a comment

TRIPS Debated As WHO Board Reaches Agreement On Universal Health Coverage

Source: IP Watch 6th Feb 2019 World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations … Continue reading

Posted in Access to Medecines, TRIPS, TRIPS flexibilities, Universal Health Coverage | Leave a comment

DPCO amendment may benefit MNC device makers by allowing price control

Source: Business Standard 4th Feb 2019, New Delhi Local industry fears global firms will register equipment as ‘innovative’ to secure price control waiver for 5 years Recent amendments to the Drug Prices Control Order (DPCO), 2013, have fuelled concerns that the authorities … Continue reading

Posted in Access to Medecines | Leave a comment

De-Coding Indian Intellectual Property LawDe-Coding Indian Intellectual Property Law

Source: SPICYIP 5TH Feb 2019,New Delhi DIPP’s Proposed Patent Rules Amendment to Legitimize India-Japan Patent Prosecution Highway We’re pleased to bring to you an insightful guest post by Roshan John, examining the amendments proposed by the recently published Draft Patent … Continue reading

Posted in Access to Medecines | Leave a comment